Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02576860 · ClinicalTrials.gov registry record · Phase 3
Study to Evaluate the Safety and Efficacy of a Once-Daily CLS001 Topical Gel Versus Vehicle
A Phase 3 study, sponsored by Maruho Co..
- Completed
- Registry status
- Phase 3
- Development phase
- 263
- Enrollment target
NCT02576860 is a Phase 3 study that has completed, run by Maruho Co.. The registered enrollment target is 263 participants.
The verdict
NCT02576860, a Phase 3 study, has completed, sponsored by Maruho Co..
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 263 participants
- Enrollment target
Study Summary
This study evaluates the safety and efficacy of once-daily application of CLS001 topical gel compared to vehicle gel in subjects with severe papulopustular rosacea.
Interventions
- DRUG Vehicle
- DRUG CLS001 (Omiganan)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 263 participants |
| Start Date | 2015-10 |
| Est. Completion | 2017-09-05 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02576860
The ClinicalTrials.gov registry entry for NCT02576860 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 263 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Maruho Co., which has 10 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Vehicle is the first listed.
NCT02576860 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02576860 about?
NCT02576860 is a clinical study titled "Study to Evaluate the Safety and Efficacy of a Once-Daily CLS001 Topical Gel Versus Vehicle". This study evaluates the safety and efficacy of once-daily application of CLS001 topical gel compared to vehicle gel in subjects with severe papulopustular rosacea.
What is the current status of trial NCT02576860?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 263 participants. The study started on 2015-10. Estimated completion is 2017-09-05.
What interventions are being tested in trial NCT02576860?
The interventions under investigation include: Vehicle (DRUG), CLS001 (Omiganan) (DRUG).
Who is sponsoring clinical trial NCT02576860?
This trial is sponsored by Maruho Co., which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.